Omnicell, Inc. (OMCL)
USD 44.18
(-2.28%)
USD 44.18
(-2.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 113.11 Million USD | -60.5% |
| 2022 | 286.37 Million USD | 59.98% |
| 2021 | 179.01 Million USD | 493.34% |
| 2020 | 30.17 Million USD | 213.67% |
| 2019 | -26.54 Million USD | -138.9% |
| 2018 | 68.22 Million USD | -61.61% |
| 2017 | 177.7 Million USD | -11.0% |
| 2016 | 199.65 Million USD | 342.84% |
| 2015 | -82.21 Million USD | 34.69% |
| 2014 | -125.88 Million USD | -20.43% |
| 2013 | -104.53 Million USD | -67.75% |
| 2012 | -62.31 Million USD | 67.51% |
| 2011 | -191.76 Million USD | -9.18% |
| 2010 | -175.63 Million USD | -3.78% |
| 2009 | -169.23 Million USD | -40.51% |
| 2008 | -120.43 Million USD | 29.08% |
| 2007 | -169.81 Million USD | -179.04% |
| 2006 | -60.85 Million USD | -231.15% |
| 2005 | -18.37 Million USD | -13.03% |
| 2004 | -16.25 Million USD | 32.8% |
| 2003 | -24.19 Million USD | -21.59% |
| 2002 | -19.89 Million USD | -20.24% |
| 2001 | -16.54 Million USD | -1205.13% |
| 2000 | -1.26 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 65.59 Million USD | -42.01% |
| 2024 Q3 | 32.89 Million USD | 17.15% |
| 2024 Q2 | 37.14 Million USD | -43.38% |
| 2023 Q2 | 204.16 Million USD | -22.6% |
| 2023 Q1 | 263.78 Million USD | -7.89% |
| 2023 Q4 | 113.11 Million USD | -26.97% |
| 2023 Q3 | 154.89 Million USD | -24.13% |
| 2023 FY | 113.11 Million USD | -60.5% |
| 2022 Q2 | 375.33 Million USD | 11.53% |
| 2022 Q1 | 336.53 Million USD | 88.0% |
| 2022 Q3 | 351.92 Million USD | -6.24% |
| 2022 Q4 | 286.37 Million USD | -18.63% |
| 2022 FY | 286.37 Million USD | 59.98% |
| 2021 FY | 179.01 Million USD | 493.34% |
| 2021 Q1 | -30.27 Million USD | -200.34% |
| 2021 Q2 | -94.17 Million USD | -211.07% |
| 2021 Q3 | 41.7 Million USD | 144.29% |
| 2021 Q4 | 179.01 Million USD | 329.19% |
| 2020 FY | 30.17 Million USD | 213.67% |
| 2020 Q1 | -55.22 Million USD | -108.09% |
| 2020 Q2 | -86.89 Million USD | -57.33% |
| 2020 Q3 | -122.69 Million USD | -41.2% |
| 2020 Q4 | 30.17 Million USD | 124.59% |
| 2019 Q1 | 77.21 Million USD | 13.18% |
| 2019 FY | -26.54 Million USD | -138.9% |
| 2019 Q2 | 44.31 Million USD | -42.61% |
| 2019 Q3 | -7.4 Million USD | -116.71% |
| 2019 Q4 | -26.54 Million USD | -258.47% |
| 2018 FY | 68.22 Million USD | -61.61% |
| 2018 Q4 | 68.22 Million USD | -51.5% |
| 2018 Q3 | 140.66 Million USD | -7.82% |
| 2018 Q2 | 152.6 Million USD | -7.19% |
| 2018 Q1 | 164.42 Million USD | -7.47% |
| 2017 Q3 | 184.86 Million USD | 10.37% |
| 2017 Q4 | 177.7 Million USD | -3.88% |
| 2017 FY | 177.7 Million USD | -11.0% |
| 2017 Q1 | 168.19 Million USD | -15.76% |
| 2017 Q2 | 167.5 Million USD | -0.41% |
| 2016 Q1 | 173.96 Million USD | 311.6% |
| 2016 Q3 | 175.95 Million USD | -4.54% |
| 2016 FY | 199.65 Million USD | 342.84% |
| 2016 Q2 | 184.31 Million USD | 5.95% |
| 2016 Q4 | 199.65 Million USD | 13.47% |
| 2015 Q2 | -88.02 Million USD | 36.92% |
| 2015 Q3 | -57.75 Million USD | 34.39% |
| 2015 Q1 | -139.55 Million USD | -10.85% |
| 2015 Q4 | -82.21 Million USD | -42.35% |
| 2015 FY | -82.21 Million USD | 34.69% |
| 2014 Q1 | -107.55 Million USD | -2.9% |
| 2014 FY | -125.88 Million USD | -20.43% |
| 2014 Q3 | -104.18 Million USD | 17.56% |
| 2014 Q4 | -125.88 Million USD | -20.83% |
| 2014 Q2 | -126.37 Million USD | -17.5% |
| 2013 Q3 | -116.19 Million USD | -33.04% |
| 2013 Q1 | -69.81 Million USD | -12.04% |
| 2013 FY | -104.53 Million USD | -67.75% |
| 2013 Q4 | -104.53 Million USD | 10.03% |
| 2013 Q2 | -87.33 Million USD | -25.09% |
| 2012 Q4 | -62.31 Million USD | -13.67% |
| 2012 Q2 | -54.07 Million USD | 73.16% |
| 2012 Q1 | -201.42 Million USD | -5.04% |
| 2012 FY | -62.31 Million USD | 67.51% |
| 2012 Q3 | -54.81 Million USD | -1.38% |
| 2011 FY | -191.76 Million USD | -9.18% |
| 2011 Q4 | -191.76 Million USD | -6.95% |
| 2011 Q3 | -179.3 Million USD | 1.08% |
| 2011 Q2 | -181.25 Million USD | -4.37% |
| 2011 Q1 | -173.66 Million USD | 1.12% |
| 2010 FY | -175.63 Million USD | -3.78% |
| 2010 Q2 | -185.15 Million USD | -2.52% |
| 2010 Q3 | -178.62 Million USD | 3.53% |
| 2010 Q4 | -175.63 Million USD | 1.67% |
| 2010 Q1 | -180.61 Million USD | -6.73% |
| 2009 Q1 | -118.85 Million USD | 1.32% |
| 2009 FY | -169.23 Million USD | -40.51% |
| 2009 Q2 | -126.42 Million USD | -6.37% |
| 2009 Q3 | -146.31 Million USD | -15.73% |
| 2009 Q4 | -169.23 Million USD | -15.66% |
| 2008 Q3 | -125.03 Million USD | -1.83% |
| 2008 FY | -120.43 Million USD | 29.08% |
| 2008 Q1 | -142.57 Million USD | 16.04% |
| 2008 Q2 | -122.78 Million USD | 13.88% |
| 2008 Q4 | -120.43 Million USD | 3.67% |
| 2007 Q1 | -64.66 Million USD | -6.27% |
| 2007 Q4 | -169.81 Million USD | 3.38% |
| 2007 Q3 | -175.74 Million USD | -2.1% |
| 2007 Q2 | -172.13 Million USD | -166.18% |
| 2007 FY | -169.81 Million USD | -179.04% |
| 2006 Q4 | -60.85 Million USD | -24.32% |
| 2006 Q3 | -48.95 Million USD | -14.01% |
| 2006 Q2 | -42.93 Million USD | -42.31% |
| 2006 FY | -60.85 Million USD | -231.15% |
| 2006 Q1 | -30.17 Million USD | -64.18% |
| 2005 FY | -18.37 Million USD | -13.03% |
| 2005 Q1 | -12.39 Million USD | 23.74% |
| 2005 Q2 | -22.02 Million USD | -77.64% |
| 2005 Q3 | -27.84 Million USD | -26.44% |
| 2005 Q4 | -18.37 Million USD | 34.01% |
| 2004 Q4 | -16.25 Million USD | 10.31% |
| 2004 Q3 | -18.12 Million USD | -10.77% |
| 2004 FY | -16.25 Million USD | 32.8% |
| 2004 Q2 | -16.36 Million USD | 21.49% |
| 2004 Q1 | -20.84 Million USD | 13.85% |
| 2003 Q2 | -25.12 Million USD | -14.93% |
| 2003 Q3 | -26.21 Million USD | -4.34% |
| 2003 Q4 | -24.19 Million USD | 7.71% |
| 2003 FY | -24.19 Million USD | -21.59% |
| 2003 Q1 | -21.85 Million USD | -9.86% |
| 2002 Q3 | -19.38 Million USD | -37.01% |
| 2002 FY | -19.89 Million USD | -20.24% |
| 2002 Q2 | -14.14 Million USD | -9.1% |
| 2002 Q1 | -12.96 Million USD | 21.65% |
| 2002 Q4 | -19.89 Million USD | -2.67% |
| 2001 FY | -16.54 Million USD | -1205.13% |
| 2001 Q4 | -16.54 Million USD | 32.78% |
| 2001 Q3 | -24.61 Million USD | -373.76% |
| 2001 Q2 | 8.99 Million USD | 47.62% |
| 2001 Q1 | 6.09 Million USD | 0.0% |
| 2000 FY | -1.26 Million USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 773.42 Million USD | 85.375% |
| GE HealthCare Technologies Inc. | 7.36 Billion USD | 98.465% |
| Sharecare, Inc. | -125.84 Million USD | 189.883% |
| Progyny, Inc. | -77.9 Million USD | 245.189% |
| Aclarion, Inc. | 94.65 Thousand USD | -119398.178% |
| CareMax, Inc. | 426.4 Million USD | 73.473% |
| Simulations Plus, Inc. | -9.83 Million USD | 1249.969% |
| CareCloud, Inc. | 11.4 Million USD | -892.028% |
| Forian Inc. | 16.95 Million USD | -566.976% |
| Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | 4409.434% |
| Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | 4409.434% |
| Minerva Surgical, Inc. | 32.74 Million USD | -245.398% |
| Definitive Healthcare Corp. | 136.95 Million USD | 17.408% |
| Zhongchao Inc. | -6.74 Million USD | 1778.071% |
| Accolade, Inc. | 55.93 Million USD | -102.237% |
| Streamline Health Solutions, Inc. | 7.37 Million USD | -1433.501% |
| Ontrak, Inc. | -8.01 Million USD | 1511.77% |
| SOPHiA GENETICS SA | -104.65 Million USD | 208.085% |
| R1 RCM Inc. | 1.56 Billion USD | 92.781% |
| Spok Holdings, Inc. | -20.9 Million USD | 641.123% |
| Privia Health Group, Inc. | -381.22 Million USD | 129.671% |
| EUDA Health Holdings Limited | 3.18 Million USD | -3450.786% |
| HeartBeam, Inc. | -16.18 Million USD | 798.69% |
| GeneDx Holdings Corp. | 20.08 Million USD | -463.049% |
| TruBridge, Inc. | 199.44 Million USD | 43.286% |
| Nutex Health, Inc. | 253.75 Million USD | 55.425% |
| Renalytix Plc | 3.85 Million USD | -2834.137% |
| Sharecare, Inc. | -125.84 Million USD | 189.883% |
| Health Catalyst, Inc. | 142.79 Million USD | 20.786% |
| 10x Genomics, Inc. | -263.91 Million USD | 142.859% |
| GoodRx Holdings, Inc. | 38.77 Million USD | -191.719% |
| SCWorx Corp. | -1077.00 USD | 10502514.113% |
| Schrödinger, Inc. | -33.18 Million USD | 440.86% |
| HealthEquity, Inc. | 529.16 Million USD | 78.625% |
| HealthStream, Inc. | -17.11 Million USD | 761.004% |
| MSP Recovery, Inc. | 667.69 Million USD | 83.06% |
| Augmedix, Inc. | -20.49 Million USD | 651.869% |
| BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 96.907% |
| Ontrak, Inc. | -8.01 Million USD | 1511.77% |
| SHL Telemedicine Ltd. | 13.15 Million USD | -759.632% |
| CareCloud, Inc. | 11.4 Million USD | -892.028% |
| Premier, Inc. | 855 Thousand USD | -13129.357% |
| Certara, Inc. | 63.24 Million USD | -78.857% |
| GeneDx Holdings Corp. | 20.08 Million USD | -463.049% |
| OneMedNet Corporation | 5.05 Million USD | -2137.913% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 96.907% |
| EUDA Health Holdings Limited | 3.18 Million USD | -3450.786% |
| HeartBeam, Inc. | -16.18 Million USD | 798.69% |
| CareCloud, Inc. | 11.4 Million USD | -892.028% |
| Mangoceuticals, Inc. | -610.32 Thousand USD | 18632.822% |
| CareMax, Inc. | 426.4 Million USD | 73.473% |
| Healthcare Triangle, Inc. | 3.08 Million USD | -3568.861% |
| National Research Corporation | 32.3 Million USD | -250.156% |
| Aclarion, Inc. | 94.65 Thousand USD | -119398.178% |
| OptimizeRx Corporation | 22.97 Million USD | -392.4% |